Abstract
To review the treatments currently used to treat mycobacteria (latent tuberculosis, clinical tuberculosis, infections due to mycobacteria), focussing on : Doses administered and duration of treatment Levels reached in different body tissues in relation to the chemical characteristics of the drugs The relation between these data and the microbiological parameters of each microorganism To review the above parameters for the new groups of drugs being investigated for treatment of the three pathologies. a. fluorquinolones b. macrolides c. rifampicins d. oxazolidinones e. tetracyclines f.- other drugs undergoing investigation
Keywords: Mycobacterium tuberculosis, rifampicin resistance, fluoroquinolones, Mycobacterium avium, M-DCMG conjugate
Anti-Infective Agents in Medicinal Chemistry
Title: Present and Future Treatment of Mycobacteria
Volume: 7 Issue: 1
Author(s): J. C. Rodriguez, I. Escribano, R. A. Gomez, E. Garcia Pachon, A. Navarro and G. Royo
Affiliation:
Keywords: Mycobacterium tuberculosis, rifampicin resistance, fluoroquinolones, Mycobacterium avium, M-DCMG conjugate
Abstract: To review the treatments currently used to treat mycobacteria (latent tuberculosis, clinical tuberculosis, infections due to mycobacteria), focussing on : Doses administered and duration of treatment Levels reached in different body tissues in relation to the chemical characteristics of the drugs The relation between these data and the microbiological parameters of each microorganism To review the above parameters for the new groups of drugs being investigated for treatment of the three pathologies. a. fluorquinolones b. macrolides c. rifampicins d. oxazolidinones e. tetracyclines f.- other drugs undergoing investigation
Export Options
About this article
Cite this article as:
Rodriguez C. J., Escribano I., Gomez A. R., Pachon Garcia E., Navarro A. and Royo G., Present and Future Treatment of Mycobacteria, Anti-Infective Agents in Medicinal Chemistry 2008; 7 (1) . https://dx.doi.org/10.2174/187152108783329816
DOI https://dx.doi.org/10.2174/187152108783329816 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
Toll-Like Receptors and Human Disease: Lessons from Single Nucleotide Polymorphisms
Current Genomics subject Index To Volume 3
Current Drug Targets Medicinal Chemistry of New Compounds to Treat Tuberculosis
Current Clinical Pharmacology Computational Approaches for Fragment-Based and De Novo Design
Current Topics in Medicinal Chemistry Magnetic Materials for the Selective Analysis of Peptide and Protein Biomarkers
Current Medicinal Chemistry A Remarkably Faster Approach Towards 1,2,3-Triazolyl Quinolines Via CuAAC in Water: Their Crystal Structure Analysis and Antibacterial Activities
Letters in Drug Design & Discovery Anti-mycobacterial Activity of 22 Iranian Endemic or Rare Plant Extracts Against Multi-drug and Extensively Drug-resistant <i>Mycobacterium tuberculosis</i>
Combinatorial Chemistry & High Throughput Screening Nanochemistry-Based Immunotherapy for HIV-1
Current Medicinal Chemistry Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope
Current Cancer Therapy Reviews Anti-Infective Protective Properties of S100 Calgranulins
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry New Developments in Antimicrobial Use in Sepsis
Current Pharmaceutical Design Anti-mycobacterial Constituents from Medicinal Plants; A Review
Mini-Reviews in Medicinal Chemistry Synthesis and Biological Activity of 2,7-Naphthyridine Derivatives: An Overview
Current Organic Chemistry Evaluation of Substituted Benzaldehydes Against Mycobacterium tuberculosis
Letters in Drug Design & Discovery Advances in Research on Pharmacological Activities and Synthesis of Oleanolic Acid Derivatives at C-3 Position
The Natural Products Journal Breath Tests in Diagnosis of Pulmonary Tuberculosis
Recent Patents on Biotechnology Antimycobacterial Natural Products from Marine Pseudopterogorgia elisabethae
Current Organic Synthesis 3-(1-Adamantylthio)-4-Phenylpyridine as a Potential Therapeutic for Methicillin-Resistant Staphylococcus aureus
Letters in Drug Design & Discovery The Role of IL-15 Signaling in the Induction of Innate Antiviral Responses
Current Signal Transduction Therapy Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance
Current Topics in Medicinal Chemistry